FinanceCity
HealthcareNSE · BSE

Morepen Laboratories Ltd.

MOREPENLAB · ISIN INE083A01026

Share price

₹51.99 -0.82%

Market capitalisation

₹2849 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹2849 Cr

Current price

₹51.99

-0.82% today

52W high

₹66.40

52W low

₹33.05

Stock P/E

30.05

P/B ratio

2.35

02 · Per share & returns

EPS (TTM)

₹1.73

Book value

₹22.17

ROE

7.86%

ROA

3.00%

Dividend yield

0.38%

Beta

0.74

03 · Financials (TTM)

By the numbers

Revenue

₹1806 Cr

+4.00% YoY

EBITDA

₹126 Cr

Net profit

₹94.87 Cr

-18.90% YoY

Profit margin

5.25%

Operating margin

3.86%

Total debt

₹208 Cr

Total cash

₹91.70 Cr

Debt / equity

0.17x

Current ratio

2.37x

Payout ratio

11.56%

04 · Analyst view

Target price

Upside

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns MOREPENLAB?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
MOREPENLAB
Exchange
NSE · BSE
CIN
ISIN
INE083A01026
BSE code
500288
Sector
Healthcare
Industry
Face value
₹2
Listing date
23 Nov 1999
Employees
Headquarters
Gurugram, India

07 · About

What is Morepen Laboratories Ltd.?

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

08 · Common questions

Frequently asked

What is the CIN of Morepen Laboratories Ltd.?+

The Corporate Identity Number for Morepen Laboratories Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Morepen Laboratories Ltd.?+

Promoter and group-holding details for Morepen Laboratories Ltd. are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Morepen Laboratories Ltd.?+

Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of approximately ₹2849 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →